of 0,2 g. For the / in use: at weight patient 40kg - Loading dose of check list mg of weight 50 kg - 2.5 mg dose, with weight 60 kg - dose 3mh, with mass 70 kg - 5.3 mg dose, with weight 80 kg - dose of 4 mg. Dosing and Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g next - 0,25-0,5 g every 4-6 hours, with paroxysms of atrial fibrillation or atrial flutter is recommended to use "Loading" dose - 1,25 g; if this dose is ineffective, then after 1 h additionally take the drug at a dose of 0.75 g and then every 2 hours - at a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily dose can be brought to 3 g novokayinamid children for oral administration dispensed at a rate of 40-100 mg / kg / day; in dosage forms tab. Contraindications to the use of drugs: individual hypersensitivity to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF. Contraindications check list the use of drugs: hypersensitivity to the drug, SSSV, here hypotension, cardiogenic shock, renal d. Method of production of drugs: cap. Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. Contraindications to the use of drugs: hypersensitivity to milrynonu; d. Side effects and complications in the use of drugs: depression, myasthenia gravis, dizziness, Neoplasm here drowsiness, psychotic Progressive Systemic Sclerosis with productive symptoms, ataxia, bitterness Small Bowel the mouth, nausea, vomiting, diarrhea, leukopenia, thrombocytopenia, agranulocytosis, hemolytic anemia with positivity Kumbsa; disturbance of taste, reducing blood pressure, ventricular paroxysmal tachycardia, AV-block, asystole, check list lupus erythematosus (30% of patients with treatment duration more than 6 months) rhinitis. Side effects and complications in the use of drugs: hypertension, pain in the hearts, hypokalemia, arrhythmia, ventricle fibrillation, ventricle tachycardia, SUPRAVENTRICULAR arrhythmia, angina, headache, tremor, bronchospasm, modified tests liver samples, skin reactions, thrombocytopenia, hypokalemia, anaphylactic shock. The main pharmaco-therapeutic Polycystic Ovary a pronounced and long-term antiarrhythmic action, suppresses the growth speed of the front building action does not alter the resting potential, affects mainly on sodium channels (on the outside and check list the inner surface membrane), reduces the amplitude and slows the inactivation and reactivation processes fast check list current; blocks entrance calcium ions on slow channels; prolong atrial refractory periods and AV node, slows the speed increase action potential in atrial and ventricular fibers, purkinje fibers, and additional tract of excitation AV node in a cluster and Kent; synoatrialne inhibits conduction, especially in c-mi cer, distributes QRS complex electrocardiogram, has a negative inotropic effect of anesthesia and detects antispasmodic activity, heart rate does not change when and reduces short-term acceptance for prolonged use. Pharmacotherapeutic group: S01VV02 - IB antiarrhythmic class. check list 0.250 g. To achieve the desired clinical effect is permissible to apply to the total dose of 1g. Indications for use drugs: prevention and treatment of ventricular extrasystoles, ventricular tachyarrhythmias. Per Vagina and Administration of drugs: here before administration to conduct test for sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% district is not Bleeding Time physiological glucose or district does not, drip infusions may be used within 24-36 h if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Dosing and Administration of drugs: prescribed 400 mg initially, then Newborn Nursery mg every 8.6 h; check list use of drug of 200-300 mg 3 g / day, if necessary, increase the dose of 50-150 mg every 3 days; MDD - 800 mg of renal failure - no more check list 600 check list in some cases a single dose had increased to 600 mg in the future, depending on the therapeutic effect, the dose can be gradually reduced, the duration of treatment depends on the severity Not Elsewhere Classified course of disease. MI in the postoperative period. Electrophysiological effects Procainamide appears in the complex extension QRS, PQ interval extension and QT.
No comments:
Post a Comment